Colorado Researchers Develop Regenerative Shot That Reverses Osteoarthritis in Animal Models
Researchers in Colorado are developing two new therapies for osteoarthritis, including a single regenerative shot that could restore affected joints to a healthy state within weeks. The treatment has shown success in reversing osteoarthritis in animal models, moving from a 'moonshot idea' to demonstrated results in two years. While still in early stages, phase one has been successful and scientists are progressing to phase 2. This could potentially transform treatment for the 33 million Americans living with the degenerative joint disease, who currently have only pain management or invasive surgery as options.
Key quotes
In two years, we were able to go from a moonshot idea to developing these therapies to demonstrating that they reverse osteoarthritis in animals
From the article
You might also wanna read
Scientists Make Progress Toward Limb Regeneration With Serum That Triggered Digit Regrowth in Mice
Scientists are researching limb regeneration in mammals, inspired by salamanders like axolotls that can regrow lost limbs in 40-50 days. A r
Stanford study finds treatment that regrows knee cartilage and reverses arthritis in mice
Stanford Medicine researchers have discovered that blocking a protein linked to aging can restore lost knee cartilage in older mice and prev
Experimental Osteoarthritis Therapies Show Joint Healing in Animal Studies, Clinical Trials Expected Within 18 Months
Researchers have developed experimental osteoarthritis therapies that show promise in animal studies, using regenerative injections and biom
AI-ECG Models Show Promise for Detecting Structural Heart Disease and Predicting Risk
AI-enabled ECG (AI-ECG) models that detect systolic and diastolic dysfunction can identify patients with structural heart disease (SHD) who
AI-Powered Imaging Reveals Obesity-Related Nerve Damage, Raises Questions About GLP-1 Drug Effects
A new study published in Nature by researchers at Helmholtz Munich used an AI imaging system to detect obesity-related nerve damage (neuropa

French SAGhE Study: Long-Term Mortality After Childhood Recombinant Growth Hormone Treatment
This preliminary report from the French SAGhE study examines long-term mortality risks in subjects who received recombinant growth hormone (

Comments
Sign in to join the conversation.
No comments yet. Be the first.